img

Global Hereditary Angioedema Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hereditary Angioedema Treatment Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Hereditary Angioedema Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hereditary Angioedema Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hereditary Angioedema Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hereditary Angioedema Treatment key manufacturers include CSL, Pharming Group, Shire plc (Takeda Pharmaceutical Company Limited), Ionis Pharmaceuticals, Attune Pharmaceuticals, BioCryst Pharmaceuticals and KalVista Pharmaceuticals, etc. CSL, Pharming Group, Shire plc (Takeda Pharmaceutical Company Limited) are top 3 players and held % sales share in total in 2022.
Hereditary Angioedema Treatment can be divided into C1 Estearse Inhibitors (Plasma Products, Recombinant Products), Selective Bradykinin B2 Receptor Antagonists (Firazyr), Kallikrein Inhibitors (Kalbitor, Takhzyro) and Others (Conventional Drugs, Pipeline Drugs), etc. C1 Estearse Inhibitors (Plasma Products, Recombinant Products) is the mainstream product in the market, accounting for % sales share globally in 2022.
Hereditary Angioedema Treatment is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Others (online pharmacies, mail pharmacies),, etc. Hospital Pharmacies provides greatest supports to the Hereditary Angioedema Treatment industry development. In 2022, global % sales of Hereditary Angioedema Treatment went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hereditary Angioedema Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL
Pharming Group
Shire plc (Takeda Pharmaceutical Company Limited)
Ionis Pharmaceuticals
Attune Pharmaceuticals
BioCryst Pharmaceuticals
KalVista Pharmaceuticals
Segment by Type
C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Kallikrein Inhibitors (Kalbitor, Takhzyro)
Others (Conventional Drugs, Pipeline Drugs)

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Others (online pharmacies, mail pharmacies)

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hereditary Angioedema Treatment market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hereditary Angioedema Treatment, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hereditary Angioedema Treatment industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Hereditary Angioedema Treatment in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hereditary Angioedema Treatment introduction, etc. Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hereditary Angioedema Treatment market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Hereditary Angioedema Treatment Market Overview
1.1 Hereditary Angioedema Treatment Product Overview
1.2 Hereditary Angioedema Treatment Market Segment by Type
1.2.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
1.2.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
1.2.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
1.2.4 Others (Conventional Drugs, Pipeline Drugs)
1.3 Global Hereditary Angioedema Treatment Market Size by Type
1.3.1 Global Hereditary Angioedema Treatment Market Size Overview by Type (2024-2034)
1.3.2 Global Hereditary Angioedema Treatment Historic Market Size Review by Type (2024-2024)
1.3.3 Global Hereditary Angioedema Treatment Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hereditary Angioedema Treatment Sales Breakdown by Type (2024-2024)
1.4.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Hereditary Angioedema Treatment Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Hereditary Angioedema Treatment Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Hereditary Angioedema Treatment Sales Breakdown by Type (2024-2024)
2 Global Hereditary Angioedema Treatment Market Competition by Company
2.1 Global Top Players by Hereditary Angioedema Treatment Sales (2024-2024)
2.2 Global Top Players by Hereditary Angioedema Treatment Revenue (2024-2024)
2.3 Global Top Players by Hereditary Angioedema Treatment Price (2024-2024)
2.4 Global Top Manufacturers Hereditary Angioedema Treatment Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hereditary Angioedema Treatment Market Competitive Situation and Trends
2.5.1 Hereditary Angioedema Treatment Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hereditary Angioedema Treatment Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2022)
2.7 Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
2.8 Key Manufacturers Hereditary Angioedema Treatment Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hereditary Angioedema Treatment Status and Outlook by Region
3.1 Global Hereditary Angioedema Treatment Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Hereditary Angioedema Treatment Historic Market Size by Region
3.2.1 Global Hereditary Angioedema Treatment Sales in Volume by Region (2024-2024)
3.2.2 Global Hereditary Angioedema Treatment Sales in Value by Region (2024-2024)
3.2.3 Global Hereditary Angioedema Treatment Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Hereditary Angioedema Treatment Forecasted Market Size by Region
3.3.1 Global Hereditary Angioedema Treatment Sales in Volume by Region (2024-2034)
3.3.2 Global Hereditary Angioedema Treatment Sales in Value by Region (2024-2034)
3.3.3 Global Hereditary Angioedema Treatment Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Hereditary Angioedema Treatment by Application
4.1 Hereditary Angioedema Treatment Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Others (online pharmacies, mail pharmacies)
4.2 Global Hereditary Angioedema Treatment Market Size by Application
4.2.1 Global Hereditary Angioedema Treatment Market Size Overview by Application (2024-2034)
4.2.2 Global Hereditary Angioedema Treatment Historic Market Size Review by Application (2024-2024)
4.2.3 Global Hereditary Angioedema Treatment Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hereditary Angioedema Treatment Sales Breakdown by Application (2024-2024)
4.3.2 Europe Hereditary Angioedema Treatment Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Hereditary Angioedema Treatment Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Hereditary Angioedema Treatment Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Hereditary Angioedema Treatment Sales Breakdown by Application (2024-2024)
5 North America Hereditary Angioedema Treatment by Country
5.1 North America Hereditary Angioedema Treatment Historic Market Size by Country
5.1.1 North America Hereditary Angioedema Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Hereditary Angioedema Treatment Sales in Volume by Country (2024-2024)
5.1.3 North America Hereditary Angioedema Treatment Sales in Value by Country (2024-2024)
5.2 North America Hereditary Angioedema Treatment Forecasted Market Size by Country
5.2.1 North America Hereditary Angioedema Treatment Sales in Volume by Country (2024-2034)
5.2.2 North America Hereditary Angioedema Treatment Sales in Value by Country (2024-2034)
6 Europe Hereditary Angioedema Treatment by Country
6.1 Europe Hereditary Angioedema Treatment Historic Market Size by Country
6.1.1 Europe Hereditary Angioedema Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Hereditary Angioedema Treatment Sales in Volume by Country (2024-2024)
6.1.3 Europe Hereditary Angioedema Treatment Sales in Value by Country (2024-2024)
6.2 Europe Hereditary Angioedema Treatment Forecasted Market Size by Country
6.2.1 Europe Hereditary Angioedema Treatment Sales in Volume by Country (2024-2034)
6.2.2 Europe Hereditary Angioedema Treatment Sales in Value by Country (2024-2034)
7 Asia-Pacific Hereditary Angioedema Treatment by Region
7.1 Asia-Pacific Hereditary Angioedema Treatment Historic Market Size by Region
7.1.1 Asia-Pacific Hereditary Angioedema Treatment Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Hereditary Angioedema Treatment Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Hereditary Angioedema Treatment Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Hereditary Angioedema Treatment Forecasted Market Size by Region
7.2.1 Asia-Pacific Hereditary Angioedema Treatment Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Hereditary Angioedema Treatment Sales in Value by Region (2024-2034)
8 Latin America Hereditary Angioedema Treatment by Country
8.1 Latin America Hereditary Angioedema Treatment Historic Market Size by Country
8.1.1 Latin America Hereditary Angioedema Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Hereditary Angioedema Treatment Sales in Volume by Country (2024-2024)
8.1.3 Latin America Hereditary Angioedema Treatment Sales in Value by Country (2024-2024)
8.2 Latin America Hereditary Angioedema Treatment Forecasted Market Size by Country
8.2.1 Latin America Hereditary Angioedema Treatment Sales in Volume by Country (2024-2034)
8.2.2 Latin America Hereditary Angioedema Treatment Sales in Value by Country (2024-2034)
9 Middle East and Africa Hereditary Angioedema Treatment by Country
9.1 Middle East and Africa Hereditary Angioedema Treatment Historic Market Size by Country
9.1.1 Middle East and Africa Hereditary Angioedema Treatment Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Hereditary Angioedema Treatment Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Hereditary Angioedema Treatment Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Hereditary Angioedema Treatment Forecasted Market Size by Country
9.2.1 Middle East and Africa Hereditary Angioedema Treatment Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Hereditary Angioedema Treatment Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 CSL
10.1.1 CSL Company Information
10.1.2 CSL Introduction and Business Overview
10.1.3 CSL Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2024-2024)
10.1.4 CSL Hereditary Angioedema Treatment Products Offered
10.1.5 CSL Recent Development
10.2 Pharming Group
10.2.1 Pharming Group Company Information
10.2.2 Pharming Group Introduction and Business Overview
10.2.3 Pharming Group Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Pharming Group Hereditary Angioedema Treatment Products Offered
10.2.5 Pharming Group Recent Development
10.3 Shire plc (Takeda Pharmaceutical Company Limited)
10.3.1 Shire plc (Takeda Pharmaceutical Company Limited) Company Information
10.3.2 Shire plc (Takeda Pharmaceutical Company Limited) Introduction and Business Overview
10.3.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Products Offered
10.3.5 Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
10.4 Ionis Pharmaceuticals
10.4.1 Ionis Pharmaceuticals Company Information
10.4.2 Ionis Pharmaceuticals Introduction and Business Overview
10.4.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Ionis Pharmaceuticals Hereditary Angioedema Treatment Products Offered
10.4.5 Ionis Pharmaceuticals Recent Development
10.5 Attune Pharmaceuticals
10.5.1 Attune Pharmaceuticals Company Information
10.5.2 Attune Pharmaceuticals Introduction and Business Overview
10.5.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Attune Pharmaceuticals Hereditary Angioedema Treatment Products Offered
10.5.5 Attune Pharmaceuticals Recent Development
10.6 BioCryst Pharmaceuticals
10.6.1 BioCryst Pharmaceuticals Company Information
10.6.2 BioCryst Pharmaceuticals Introduction and Business Overview
10.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2024-2024)
10.6.4 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Products Offered
10.6.5 BioCryst Pharmaceuticals Recent Development
10.7 KalVista Pharmaceuticals
10.7.1 KalVista Pharmaceuticals Company Information
10.7.2 KalVista Pharmaceuticals Introduction and Business Overview
10.7.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales, Revenue and Gross Margin (2024-2024)
10.7.4 KalVista Pharmaceuticals Hereditary Angioedema Treatment Products Offered
10.7.5 KalVista Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hereditary Angioedema Treatment Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hereditary Angioedema Treatment Industrial Chain Analysis
11.4 Hereditary Angioedema Treatment Market Dynamics
11.4.1 Hereditary Angioedema Treatment Industry Trends
11.4.2 Hereditary Angioedema Treatment Market Drivers
11.4.3 Hereditary Angioedema Treatment Market Challenges
11.4.4 Hereditary Angioedema Treatment Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hereditary Angioedema Treatment Distributors
12.3 Hereditary Angioedema Treatment Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Table 2. Major Company of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Table 3. Major Company of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Table 4. Major Company of Others (Conventional Drugs, Pipeline Drugs)
Table 5. Global Hereditary Angioedema Treatment Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Hereditary Angioedema Treatment Sales by Type (2024-2024) & (K Units)
Table 7. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Hereditary Angioedema Treatment Sales by Type (2024-2024) & (US& Million)
Table 9. Global Hereditary Angioedema Treatment Market Share in Value by Type (2024-2024)
Table 10. Global Hereditary Angioedema Treatment Price by Type (2024-2024) & (USD/Unit)
Table 11. Global Hereditary Angioedema Treatment Sales by Type (2024-2034) & (K Units)
Table 12. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Hereditary Angioedema Treatment Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Hereditary Angioedema Treatment Sales Market Share in Value by Type (2024-2034)
Table 15. Global Hereditary Angioedema Treatment Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Hereditary Angioedema Treatment Sales by Type (2024-2024) & (K Units)
Table 17. North America Hereditary Angioedema Treatment Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Hereditary Angioedema Treatment Sales (K Units) by Type (2024-2024)
Table 19. Europe Hereditary Angioedema Treatment Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Hereditary Angioedema Treatment Sales (K Units) by Type (2024-2024)
Table 21. Asia-Pacific Hereditary Angioedema Treatment Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Hereditary Angioedema Treatment Sales (K Units) by Type (2024-2024)
Table 23. Latin America Hereditary Angioedema Treatment Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Hereditary Angioedema Treatment Sales (K Units) by Type (2024-2024)
Table 25. Middle East and Africa Hereditary Angioedema Treatment Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Hereditary Angioedema Treatment Sales by Company (2024-2024) & (K Units)
Table 27. Global Hereditary Angioedema Treatment Sales Share by Company (2024-2024)
Table 28. Global Hereditary Angioedema Treatment Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Hereditary Angioedema Treatment Revenue Share by Company (2024-2024)
Table 30. Global Market Hereditary Angioedema Treatment Price by Company (2024-2024) & (USD/Unit)
Table 31. Global Hereditary Angioedema Treatment Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hereditary Angioedema Treatment as of 2022)
Table 34. Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
Table 35. Key Manufacturers Hereditary Angioedema Treatment Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Hereditary Angioedema Treatment Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Hereditary Angioedema Treatment Sales by Region (2024-2024) & (K Units)
Table 39. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Hereditary Angioedema Treatment Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Hereditary Angioedema Treatment Sales Market Share in Value by Region (2024-2024)
Table 42. Global Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 43. Global Hereditary Angioedema Treatment Sales by Region (2024-2034) & (K Units)
Table 44. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Hereditary Angioedema Treatment Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Hereditary Angioedema Treatment Sales Market Share in Value by Region (2024-2034)
Table 47. Global Hereditary Angioedema Treatment Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Hereditary Angioedema Treatment Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Hereditary Angioedema Treatment Sales by Application (2024-2024) & (K Units)
Table 50. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Hereditary Angioedema Treatment Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Hereditary Angioedema Treatment Sales Market Share in Value by Application (2024-2024)
Table 53. Global Hereditary Angioedema Treatment Price by Application (2024-2024) & (USD/Unit)
Table 54. Global Hereditary Angioedema Treatment Sales by Application (2024-2034) & (K Units)
Table 55. Global Hereditary Angioedema Treatment Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Hereditary Angioedema Treatment Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Hereditary Angioedema Treatment Sales Market Share in Value by Application (2024-2034)
Table 58. Global Hereditary Angioedema Treatment Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Hereditary Angioedema Treatment Sales by Application (2024-2024) (K Units)
Table 60. North America Hereditary Angioedema Treatment Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Hereditary Angioedema Treatment Sales by Application (2024-2024) (K Units)
Table 62. Europe Hereditary Angioedema Treatment Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Hereditary Angioedema Treatment Sales by Application (2024-2024) (K Units)
Table 64. Asia-Pacific Hereditary Angioedema Treatment Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Hereditary Angioedema Treatment Sales by Application (2024-2024) (K Units)
Table 66. Latin America Hereditary Angioedema Treatment Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2024-2024) (K Units)
Table 68. Middle East and Africa Hereditary Angioedema Treatment Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Hereditary Angioedema Treatment Sales by Country (2024-2024) & (K Units)
Table 70. North America Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Hereditary Angioedema Treatment Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2024)
Table 73. North America Hereditary Angioedema Treatment Sales by Country (2024-2034) & (K Units)
Table 74. North America Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Hereditary Angioedema Treatment Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Hereditary Angioedema Treatment Sales by Country (2024-2024) & (K Units)
Table 78. Europe Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Hereditary Angioedema Treatment Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Hereditary Angioedema Treatment Sales by Country (2024-2034) & (K Units)
Table 82. Europe Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Hereditary Angioedema Treatment Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Hereditary Angioedema Treatment Sales by Region (2024-2024) & (K Units)
Table 86. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Hereditary Angioedema Treatment Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Hereditary Angioedema Treatment Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Hereditary Angioedema Treatment Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Hereditary Angioedema Treatment Sales by Country (2024-2024) & (K Units)
Table 94. Latin America Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Hereditary Angioedema Treatment Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Hereditary Angioedema Treatment Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Hereditary Angioedema Treatment Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2024-2024) & (K Units)
Table 102. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Hereditary Angioedema Treatment Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share in Value by Country (2024-2034)
Table 109. CSL Company Information
Table 110. CSL Introduction and Business Overview
Table 111. CSL Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 112. CSL Hereditary Angioedema Treatment Product
Table 113. CSL Recent Development
Table 114. Pharming Group Company Information
Table 115. Pharming Group Introduction and Business Overview
Table 116. Pharming Group Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 117. Pharming Group Hereditary Angioedema Treatment Product
Table 118. Pharming Group Recent Development
Table 119. Shire plc (Takeda Pharmaceutical Company Limited) Company Information
Table 120. Shire plc (Takeda Pharmaceutical Company Limited) Introduction and Business Overview
Table 121. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 122. Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Product
Table 123. Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table 124. Ionis Pharmaceuticals Company Information
Table 125. Ionis Pharmaceuticals Introduction and Business Overview
Table 126. Ionis Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 127. Ionis Pharmaceuticals Hereditary Angioedema Treatment Product
Table 128. Ionis Pharmaceuticals Recent Development
Table 129. Attune Pharmaceuticals Company Information
Table 130. Attune Pharmaceuticals Introduction and Business Overview
Table 131. Attune Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 132. Attune Pharmaceuticals Hereditary Angioedema Treatment Product
Table 133. Attune Pharmaceuticals Recent Development
Table 134. BioCryst Pharmaceuticals Company Information
Table 135. BioCryst Pharmaceuticals Introduction and Business Overview
Table 136. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 137. BioCryst Pharmaceuticals Hereditary Angioedema Treatment Product
Table 138. BioCryst Pharmaceuticals Recent Development
Table 139. KalVista Pharmaceuticals Company Information
Table 140. KalVista Pharmaceuticals Introduction and Business Overview
Table 141. KalVista Pharmaceuticals Hereditary Angioedema Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 142. KalVista Pharmaceuticals Hereditary Angioedema Treatment Product
Table 143. KalVista Pharmaceuticals Recent Development
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Hereditary Angioedema Treatment Market Trends
Table 147. Hereditary Angioedema Treatment Market Drivers
Table 148. Hereditary Angioedema Treatment Market Challenges
Table 149. Hereditary Angioedema Treatment Market Restraints
Table 150. Hereditary Angioedema Treatment Distributors List
Table 151. Hereditary Angioedema Treatment Downstream Customers
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Hereditary Angioedema Treatment Product Picture
Figure 2. Global Hereditary Angioedema Treatment Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Hereditary Angioedema Treatment Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Hereditary Angioedema Treatment Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
Figure 6. Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Selective Bradykinin B2 Receptor Antagonists (Firazyr)
Figure 8. Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Kallikrein Inhibitors (Kalbitor, Takhzyro)
Figure 10. Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Others (Conventional Drugs, Pipeline Drugs)
Figure 12. Global Others (Conventional Drugs, Pipeline Drugs) Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Global Hereditary Angioedema Treatment Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Hereditary Angioedema Treatment Sales Market Share by Type in 2022 & 2034
Figure 15. North America Hereditary Angioedema Treatment Sales Market Share in Volume by Type in 2022
Figure 16. North America Hereditary Angioedema Treatment Sales Market Share in Value by Type in 2022
Figure 17. Europe Hereditary Angioedema Treatment Sales Market Share in Volume by Type in 2022
Figure 18. Europe Hereditary Angioedema Treatment Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Value by Type in 2022
Figure 21. Latin America Hereditary Angioedema Treatment Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Hereditary Angioedema Treatment Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Hereditary Angioedema Treatment Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Hereditary Angioedema Treatment Revenue in 2022
Figure 27. Hereditary Angioedema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Hospital Pharmacies
Figure 29. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Product Picture of Retail Pharmacies
Figure 31. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 32. Product Picture of Others (online pharmacies, mail pharmacies)
Figure 33. Global Others (online pharmacies, mail pharmacies) Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Global Hereditary Angioedema Treatment Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Hereditary Angioedema Treatment Sales Market Share by Application in 2022 & 2034
Figure 36. North America Hereditary Angioedema Treatment Sales Market Share in Volume by Application in 2022
Figure 37. North America Hereditary Angioedema Treatment Sales Market Share in Value by Application in 2022
Figure 38. Europe Hereditary Angioedema Treatment Sales Market Share in Volume by Application in 2022
Figure 39. Europe Hereditary Angioedema Treatment Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Hereditary Angioedema Treatment Sales Market Share in Value by Application in 2022
Figure 42. Latin America Hereditary Angioedema Treatment Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Hereditary Angioedema Treatment Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Hereditary Angioedema Treatment Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Hereditary Angioedema Treatment Manufacturing Cost Structure
Figure 47. Hereditary Angioedema Treatment Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries